IMP dehydrogenase: Mechanism of action and inhibition

Current Medicinal Chemistry

Volumn 6, Issue 7, 1999, Pages 545-560

  Hedstrom, Lizbeth ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE INHIBITOR; INOSINE PHOSPHATE; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN; SELENAZOFURIN; TIAZOFURIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING SITE; DRUG MECHANISM; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PURINE SYNTHESIS; SPECIES DIFFERENCE; STRUCTURE ANALYSIS;

EID: 0032804406     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Jackson, R., Weber, G., and Morris, H.P., IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature, 1975,. 256, 331-333.
2. Weber, G., Prajda, N., and Jackson, R., Key enzymes of IMP metabolism: transformation-and proliferation-linked alterations in gene expression. Adv. Enz. Reg., 1976, 14, 3-24.
3. Sokoloski, J.A., Blair, O.C., and Sartorelli, A.C., Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-monophosphate dehydrogenase. Cancer Res., 1986, 46, 2314-2319.
4. Sherley, J.L., Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J. Biol. Chem., 1991, 266, 24815-24828.
5. Liu, Y., Bohn, S.A., and Sherley, J.L., Inosine-5-'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. Mol. Biol. Cell, 1998, 9, 15-28.
6. Weber, G., Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes memorial lecture. Cancer Res., 1983, 43, 3466-3492.
7. Robins, R., Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors. Nucleosides & Nucleotides, 1982, 1, 35-44.
8. Malinoski, F. and Stollar, V., Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells. Virol., 1981, 110, 281-291.
9. Florey, H.W., Gilliver, K., Jennings, M.A., and Sanders, A.G., Mycophenolic acid, an antibiotic from Penicillium brevicompactum Dierckx. Lancet, 1946, i, 46-49.
10. Webster, H.K. and Whaun, J.M., Antimalarial properties of bredinin. Prediction based on identification of differences in human host-parasite purine metabolism. J. Clin. Invest., 1982, 70, 461-469.
11. Quinn, C., Bugeja, V., Gallagher, J., and Whittaker, P., The effect of mycophenolic acid on the cell cycle of Candida albicans. Mycopathologia, 1990, 111, 165-168.
12. Wilson, K., Berens, R.L., Sifri, C.D., and Ullman, B., Amplification of the inosinate dehydrogenase gene in Trypanosoma brucei gambienese due to an increase in chromosome copy number. J. Biol. Chem., 1994, 269, 28979-28987.
13. Mizuno, K., Tsujino, M., Takada, M., Hayashi, M., Atsumi, K., Asano, K., and Matsuda, T., Studies of bredinin. I Isolation, characterization and biological properties. J. Antibiot., 1974, 27, 775-782.
14. Abraham, E.P., The effect of mycophenolic acid on the growth of Staphylococcus aureus in heart broth. Biochem. J., 1945, 39, 398-408.
15. O'Gara, M.J., Lee, C.-H., Weinberg, G.A., Nott, J.M., and Queener, S.F., IMP Dehydrogenase from Pneomocystis carinii as a potential drug target. Antimicrob. Agents Chemother., 1997, 41, 40-48.
16. Hupe, D., Azzolina, B., and Behrens, N., IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid. J. Biol. Chem., 1986, 261, 8363-8369.
17. Verham, R., Meek, T.D., Hedstrom, L., and Wang, C.C., Purification, characterization and kinetic analysis of inosirie monophosphate dehydrogenase of Tritrichomonas foetus. Mol. Biochem. Parasit., 1987, 24, 1-12.
18. Kerr, K., The role of carboxylate residues in the mechanism of E. coli IMP dehydorgenase., in Department of Biochemistry. 1998, Brandeis University: Waltham, MA.
19. Xiang, B., Taylor, J.C., and Markham, G.D., Monovalent cation activation and kinetic mechanism of inosine 5'-monophosphate dehydrogenase. J. Biol. Chem., 1996, 271, 1435-1440.
20. Wu, T. and Scrimgeour, K.G., Properties of inosinic acid dehydrogenase from Bacillus subtilis. II. Kinetic properties. Can. J. Biochem., 1973, 51, 1391-1398.
21. Zhou, X., Cahoon, M., Rosa, P., and Hedstrom, L., Expression, purification and charcterization of inosine-5'-monophosphate dehydrogenase from Borrelia burgdorferi. J. Biol. Chem., 1997, 272, 21977-21981.
22. Sintchak, M.D., Fleming, M.A., Futer, O., Raybuck, S.A., Chambers, S.P., Caron, P.R., Murcko, M., and Wilson, K.P., Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressarit mycophenolic acid. Cell, 1996, 85, 921-930.
23. Colby, T.D., Vanderveen, K., Strickler, M.D., Markham, G.D., and Goldstein, B.M., Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc. Natl. Acad. Sci., USA, 1999, in press.
24. Ivanovics, G., Marjai, E., and Dobozy, A., The growth of purine mutants of Bacillus anthracis in the body of the mouse. J. Gen. Microbiol., 1968, 53, 147-162.
25. McFarland, W.C. and Stocker, B.A., Effect of different purine auxotrophic strains on mouse virulence of a Vi positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb. Pathog., 1987, 3, 129-141.
26. Noreiga, F.R., Losonsky, G., Lauderbaugh, C., Liao, F.M., Wang, J.Y., and Levine, M.M., Engineered ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity and potential efficacy as a mucosal vaccine. Infection and Immunity, 1996, 64, 3055-3061.
27. Straley, S.C. and Harmon, P.A., Growth in mouse of peritoneal macrophages of Yersinia pestis lacking established virulence determinants. Infect. Immun., 1984, 45, 649-654.
28. Wu, J.C., Mycophenolate mofetil: molecular mechanisms of action. Pers. Dru Disc. Des., 1994, 2, 185-204.
29. Magasanik, B., Moyed, H.S., and Gehring, L.B., Enzymes essential for the biosynthesis of nucleic acid guanine; inosine 5'-phosphate dehydrogenase of Aerobacter aerogenes. J. Biol. Chem., 1957, 226, 339.
30. Anderson, J. and Sartorelli, A., Inosinic acid dehydrogenase of sarcoma 180 cells. J. Biol. Chem., 1968, 243, 4762-4768.
31. Holmes, E., Pehlke, D., and Kelley, W., Human IMP dehydrogenase. Kinetics and regulatory properties. Biochim. Biophys. Acta, 1974, 364, 209-217.
32. Jackson, R., Morris, H., and Weber, G., Partial purification, properties and regulation of inosine 5'-phosphate dehydrogenase in normal and malignant rat tissues. Biochem. J., 1977, 166, 1-10.
33. Wu, T. and Scrimgeour, K., Properties of inosinic acid dehydrogenase from Bacillus subtilis. I. Purification and physical properties. Can. J. Biochem., 1973, 51, 1380-1390.
34. Krishnaiah, K., Inosinic acid 5'-monophosphate dehydrogenase of Escherichia coli: Purification by affinity chromatography and some properties. Arch. Biochem. Biophys., 1975, 170, 567-575.
35. Gilbert, H., Lowe, C., and Drabble, W., Inosine 5'-monophosphate dehydrogenase of Escherichia coli. Biochem. J., 1979, 183, 481-494.
36. Turner, J. and King, J., Inosine 5'-phosphate dehydrogenase of pea seeds. Biochem. J., 1961, 79, 147-151.
37. Atkins, C., Shelp, B., and Storer, P., Purification and properties of inosine monophosphate oxidoreductase from nitrogen-fixing nodules of cowpea (Vigna unguiculata L. Walp.). Arch. Biochem. Biophys., 1985, 236, 807-814.
38. Carr, S.F., Papp, E., Wu, J.C., and Natsumeda, Y., Characterization of human type I and type II IMP dehydrogenases. J. Biol. Chem., 1993, 268, 27286-27290.
39. Hager, P.W., Collart, F.R., Huberman, E., and Mitchell, B.S., Recombinant human inosinate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem. Pharm., 1995, 49, 1323-1329.
40. Huete-Perez, J.A., Wu, J.C., Witby, F.G., and Wang, C.C., Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus. Biochemistry, 1995, 34, 13889-13894.
41. Fleming, M.A., Chambers, S.P., Connelly, P.R., Nimmesgern, E., Fox, T., Bruzzese, F.J., Hoe, S.T., Fulghum, J.R., Livingston, D.J., Stuver, C.M., Sintchak, M.D., Wilson, K.P., and Thomson, J.A., Inhibition of IMPDH by mycophenolic acid: dissection of forward and reverse pathways using capillary electrophoresis. Biochemistry, 1996, 35, 6990-6997.
42. Kohler, G.A., White, T.C., and Agabian, N., Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid . J. Bact., 1997, 179, 2331-2338.
43. Ikegami, T., Natsumeda, Y., and Weber, G., Purification of IMP dehydrogenase from rat hepatoma 3924A. Life Sciences, 1987, 40, 2277-2282.
44. Heyde, E. and Morrison, J., Studies on inosine monophosphate dehydrogenase. An associating-dissociating system. Biochim. Biophys. Acta, 1976, 429, 635-644.
45. Whitby, F.G., Luecke, H., Kuhn, P., Somoza, J.R., Huete-Perez, J.A., Philips, J.D., Hill, C.P., Fletterick, R.J., and Wang, C.C., Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex. Biochemistry, 1997, 36, 10666-10674.
46. Wang, W., Papov, V.V., Minakawa, N., Matsuda, A., Biemann, K., and Hedstrom, L., Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate. Biochemistry, 1996, 35, 95-101.
47. Antonino, L.C. and Wu, J.C., Human IMP dehydrogenase catalyzes the dehalogenation of 2-fluoro-and 2-chloroinosine 5'-monophosphate in the absence of NAD. Biochemistry, 1994, 33, 1753-1759.
48. Heyde, E., Nagabhushanam, A., Vonarx, M., and Morrison, J., Studies on inosine monophosphate dehydrogenase. Steady state kinetics. Biochim. Biophys. Acta, 1976, 429, 645-660.
49. Hampton, A., Reactions of ribonucleotide derivatives of purine analogues at the catalytic site of inosine 5'-phophate dehydrogenase. J. Biol. Chem., 1963, 238, 3068-3074.
50. Hampton, A., Brox, L., and Bayer, M., Analogs of inosine 5'-phosphate with phosphorus-nitrogen and phosphorus-sulfur bonds. Binding and kinetic studies with inosine 5'-phosphate dehydrogenase. Biochem., 1969, 8, 2303-2311.
51. Miller, R. and Adamczyk, D., Inosine 5'-monophosphate dehydrogenase from Sarcoma 180 cells-substrate and inhibitor specificity. Biochem. Pharm., 1976, 25, 883-888.
52. Bouhss, A., Sakamoto, H., Palibroda, N., Chiriac, M., Sarfati, R., Smith, J.M., Craescu, C.T., and Barzu, O., Enzymatic synthesis of guanine nucleotides with 15N at the 2-amino group of the purine ring. Anal. Biochem., 1995, 225, 18-23.
53. Wang, W. and Hedstrom, L., The kinetic mechanism of human inosine 5'-monophosphate type II: random addition of substrates, ordered release of products. Biochemistry, 1997, 36, 8479-8483.
54. You, K., Stereospecificity for nicotinamide nucleotides in enzymatic and chemical hydrid transfer reactions. CRC Crit. Rev. Biochem., 1985, 17, 313-415.
55. Xiang, B. and Markham, G.D., Probing the mechanism of inosine monophosphate dehydrogenase with kinetic isotope effects and NMR determination of the hydride transfer stereospecificity. Arch. Biochem. Biophys., 1997, 348, 378-382.
56. Gilbert, H. and Drabble, W., Active-site modification of native and mutant forms of inosine 5'-monophosphate dehydrogenase from Escherichia coli K12. Biochem. J., 1980, 191, 533-541.
57. Brox, L. and Hampton, A., Inosine 5'-phosphate dehydrogenase. Kinetic mechanism and evidence for selective reaction of the 6-chloro analog of inosine 5'-phosphate with a cysteine residue at the inosine 5'-phophate site. Biochemistry, 1968, 7, 2589-2596.
58. Matsuda, A., Minakawa, N., Sasaki, T., and Ueda, T., The design, synthesis and antileukemic activity of 5-alkynyl-1-β-D-ribofuranosylimidazole-4-caraboxamides. Chem. Pharm. Bull., 1988, 36, 2730-2733.
59. Zhang, H.-Z., Rao, K., Carr, S.F., Papp, E., Straub, K., Wu, J., and Fried, J., Rationally designed inhibitors of inosine monophosphate dehydrogenase. J. Med. Chem., 1997, 40, 4-8.
60. Antonino, L.C., Straub, K., and Wu, J.C., Probing the active site of human IMP dehydrogenase using halogenated purine riboside 5′ monophosphates and covalent modification reagents. Biochemistry, 1994, 33, 1760-1765.
61. Skibo, E. and Meyer, R., Inhibition of inosinic acid dehydrogenase by 8-substituted purine nucleotides. J. Med. Chem., 1981, 24, 1155-1161.
62. Wu, J.C., Carr, S.F., Antonino, L.C., Papp, E., and Pease, J.H., Formation and rate determining hydrolysis of a covalent intermediate by human type II IMP dehydrogenase. FASEB J., 1995, 9, A1337.
63. Link, J.O. and Straub, K., Trapping of an IMP dehydrogenase-substrate covalent interemediate by mycophenolic acid. J. Am. Chem. Soc., 1996, 118, 2091-2092.
64. Hampton, A. and Nomura, A., Inosine 5'-phosphate dehydrogenase. Site of inhibition by guanosine 5'-phosphate and of inactivation by 6-chloro-and 6-mercaptopurine ribonucleoside 5'-phosphates. Biochem., 1967, 6, 679-689.
65. Xiang, B. and Markham, G.D., The conformation of inosine-5'-monphosphate (IMP) bound to IMP dehydrogenase determined by transferred nuclear overhauser effect spectroscopy. J. Biol. Chem., 1996, 271, 27531-27535.
66. Digits, J.A. and Hedstrom, L., Kinetic mechanism of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase. Biochemistry, 1999, 38, 2295-2306.
67. Kerr, K.M. and Hedstrom, L., The roles of conserved carboxylate residues in IMP dehydrogenase and identification of a transition state analog. Biochemistry, 1997, 36, 13365-13373.
68. Bruzzese, F.J. and Connelly, P.R., Allosteric properties of inosine monophosphate dehydrogenase revealed through the thermodynamics of binding of inosine 5'-monphosphate and mycophenolic acid. Temperature dependent heat capacity of binding as a signature of ligand coupled conformational equilibria. Biochemistry, 1997, 36, 10428-10438.
69. Hedstrom, L. and Wang, C.C., Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism. Biochemistry, 1990, 29, 849-554.
70. Heyde, E. and Morrison, J., Studies on inosine monophosphate dehydrogenase. Isotope exchange at equilibrium. Biochim. Biophys. Acta, 1976, 429, 661-671.
71. Nimmesgern, E., Fox, T., Fleming, M.A., and Thomson, J.A., Conformational changes and stabilization of inosine 5'-monophosphate dehydrogenase associated with ligand binding and inhibition by mycoohenolic acid. J. Biol. Chem., 1996, 271, 19421-19427.
72. Koyama, H. and Tsuji, M., Genetic and biochemical studeis on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells. Biochem. Pharm., 1983, 32, 3527-3553.
73. Smith, C., Fontenelle, L., Muzik, H., Paterson, A., Unger, H., Brox, L., and Henderson, J., Inhibitors of inosinate dehydrogenase activity in Ehrlich ascites tumor cells in vitro. Biochem. Pharm., 1974, 23, 2727-2735.
74. Cooney, D., Jayaram, H., Gebeyehu, G., Betts, C., Kelley, J., Marquez, V., and Johns, D., The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydroganase-inhibitory properties. Biochem. Pharm., 1982, 31, 2133-2136.
75. Natsumeda, Y., Ohno, S., Kawasaki, H., Konno, Y., Weber, G., and Suzuki, K., Two distinct cDNAs for human IMP dehydrogenase. J. Biol. Chem., 1990, 265, 5292-5295.
76. Wang, W. and Hedstrom, L., A potent "fat base" nucleotide inhibitor of IMP dehydrogenase. Biochemistry, 1998, 37, 11949-11952.
77. Gebeyehu, G., Marquez, V., Van Cott, A., Cooney, D., Kelley, J., Jayaram, H., Ahluwalia, G., Dion, R., Wilson, Y., and Johns, D., Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interact ons with IMP dehydrogenase. J. Med. Chem., 1985, 28, 99-105.
78. Yamada, Y., Natsumeda, Y., and Weber, G., Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase. Biochem., 1988, 27, 2193-2196.
79. Miles, D.L., Miles, D.W., Redington, P., and Eyring, H., Theoretical studies of the conformational properties of ribavirin. Proc. Natl. Acad. Sci., USA, 1976, 73, 4257-4260.
80. Wolfenden, R., Transition state analog inhibitors and enzyme catalysis. Ann. Rev. Biochem. Bioengin., 1976, 5, 271-306.
81. Bartlett, P.A. and Marlowe, C.K., Biochemistry, 1983, 22, 4618-4624.
82. Phillips, M.A., Hedstrom, L., and Rutter, W.J., Guanidine derivatives restore activity to carboxypeptidase lacking Arginine-127. Prot. Sci., 1992, 1, 517.
83. Marquez, V., Tseng, C.K.H., Gebeyehu, G., Cooney, D.A., Ahluwalia, G.S., Kelley, J.A., Dalal, M., Fuller, R.W., Wilson, Y.A., and Johns, D.G., Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis. J. Med. Chem., 1986, 29, 1726-1731.
84. Goldstein, B., Bell, J., and Marquez, V., Dehydrogenase binding by tiazofurin anabolites. J. Med. Chem., 1990, 33, 1123-1127.
85. Burling, F. and Goldstein, B., Computational studies of nonbonded sulfur-oxygen and selenium-oxygen interactions in the thiazole and selenazole nucleosides. J. Am. Chem. Soc., 1992, 114, 2313-2320.
86. Li, H., Hallows, W.H., Punzi, J.S., Marquez, V.E., Carrell, H.L., Pankiewicz, K.W., Watanabe, K.A., and Goldstein, B.M., Crystallographic studies of two alcohol dehydrogenas-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin. Biochemistry, 1994, 33, 23-32.
87. Makara, G.M., Kesseru, G.M., Kajtar-Peredy, M., and Anderson, W.K., Nuclear magnetic resonance and molecular modeling study on mycophenolic acid: implications for binding to inosine monophosphate dehydrogenase. J. Med. Chem., 1996, 39, 1236-1242.
88. Lesiak, K., Watanabe, K.A., Majumdar, A., Powell, J., Seidman, M., Vanderveen, K., Goldstein, B.M., and Pankiewicz, K.W., Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation resistant MAD analogue of NAD. J. Med. Chem., 1998, 41, 618-622.
89. Farazi, T., Leichman, J., Harris, T., Cahoon, M., and Hedstrom, L., Isolation and characterization of mycophenolic acid resistant mutants of inosine 5'monophosphate dehydrogenase. J. Biol. Chem., 1997, 272, 961-965.